{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:07:53Z","timestamp":1777489673489,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"DIUE de la Generalitat de Catalunya","award":["2014-SGR-680"],"award-info":[{"award-number":["2014-SGR-680"]}]},{"name":"DIUE de la Generalitat de Catalunya","award":["2017-SGR-1497"],"award-info":[{"award-number":["2017-SGR-1497"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00210"],"award-info":[{"award-number":["PI14\/00210"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00053"],"award-info":[{"award-number":["PI18\/00053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF-2017-87629-R"],"award-info":[{"award-number":["SAF-2017-87629-R"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF-2015-69762-R"],"award-info":[{"award-number":["SAF-2015-69762-R"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2015-74627-JIN"],"award-info":[{"award-number":["SAF2015-74627-JIN"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["PID2019-109240RB-I00"],"award-info":[{"award-number":["PID2019-109240RB-I00"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["MDM-2014-0370"],"award-info":[{"award-number":["MDM-2014-0370"]}]},{"name":"\u201cMar\u00eda de Maeztu\u201d Programme for Units of Excellence in R&D"},{"name":"Instituto de Salud Carlos III: Red de Trastornos Adictivos"},{"DOI":"10.13039\/501100006751","name":"CIBER de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"CIBER de Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIBER de Enfermedades Neurodegenerativas"},{"name":"Spanish Ministry of Economy and Competitiveness"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Schizophrenia (SCZ) has been associated with serotonergic and endocannabinoid systems dysregulation, but difficulty in obtaining in vivo neurological tissue has limited its exploration. We investigated CB1R-5-HT2AR heteromer expression and functionality via intracellular pERK and cAMP quantification in olfactory neuroepithelium (ON) cells of SCZ patients non-cannabis users (SCZ\/nc), and evaluated whether cannabis modulated these parameters in patients using cannabis (SCZ\/c). Results were compared vs healthy controls non-cannabis users (HC\/nc) and healthy controls cannabis users (HC\/c). Further, antipsychotic effects on heteromer signaling were tested in vitro in HC\/nc and HC\/c. Results indicated that heteromer expression was enhanced in both SCZ groups vs HC\/nc. Additionally, pooling all 4 groups together, heteromer expression correlated with worse attentional performance and more neurological soft signs (NSS), indicating that these changes may be useful markers for neurocognitive impairment. Remarkably, the previously reported signaling properties of CB1R-5-HT2AR heteromers in ON cells were absent, specifically in SCZ\/nc treated with clozapine. These findings were mimicked in cells from HC\/nc exposed to clozapine, suggesting a major role of this antipsychotic in altering the quaternary structure of the CB1R-5-HT2AR heteromer in SCZ\/nc patients. In contrast, cells from SCZ\/c showed enhanced heteromer functionality similar to HC\/c. Our data highlight a molecular marker of the interaction between antipsychotic medication and cannabis use in SCZ with relevance for future studies evaluating its association with specific neuropsychiatric alterations.<\/jats:p>","DOI":"10.1093\/schbul\/sbaa038","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T20:16:19Z","timestamp":1582834579000},"page":"1547-1557","source":"Crossref","is-referenced-by-count":27,"title":["Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-6716","authenticated-orcid":false,"given":"Daniel","family":"Guinart","sequence":"first","affiliation":[{"name":"Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain"},{"name":"Department of Psychiatry and Legal Medicine, Autonomous University of Barcelona, Barcelona, Spain"},{"name":"Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-5753","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Galindo","sequence":"additional","affiliation":[{"name":"Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain"},{"name":"Department of Psychiatry, University of Cambridge, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Cuenca-Royo","sequence":"additional","affiliation":[{"name":"Integrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Barrera-Conde","sequence":"additional","affiliation":[{"name":"Integrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain"},{"name":"Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel J","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Avil\u00e9s","sequence":"additional","affiliation":[{"name":"Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph U","family":"Correll","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, New York, NY"},{"name":"Department of Child and Adolescent Psychiatry, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric I","family":"Canela","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Casad\u00f3","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-2928","authenticated-orcid":false,"given":"Arnau","family":"Cordomi","sequence":"additional","affiliation":[{"name":"Laboratori de Medicina Computacional, Unitat de Bioestad\u00edstica, Facultat de Medicina, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[{"name":"Laboratori de Medicina Computacional, Unitat de Bioestad\u00edstica, Facultat de Medicina, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[{"name":"Integrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain"},{"name":"Department of Psychiatry and Legal Medicine, Autonomous University of Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental G21, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-0939","authenticated-orcid":false,"given":"Patricia","family":"Robledo","sequence":"additional","affiliation":[{"name":"Integrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain"},{"name":"Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"3","key":"2020120619172429000_CIT0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"key":"2020120619172429000_CIT0002","first-page":"357","article-title":"Global economic burden of schizophrenia: a systematic review","volume":"12","author":"Chong","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2020120619172429000_CIT0003","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbr.2015.12.034","article-title":"Neuronal and brain morphological changes in animal models of schizophrenia","volume":"301","author":"Flores","year":"2016","journal-title":"Behav Brain Res"},{"issue":"3","key":"2020120619172429000_CIT0004","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2010.06.036","article-title":"Identifying gene regulatory networks in schizophrenia","volume":"53","author":"Potkin","year":"2010","journal-title":"Neuroimage"},{"issue":"1","key":"2020120619172429000_CIT0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","article-title":"The role of genes, stress, and dopamine in the development of schizophrenia","volume":"81","author":"Howes","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2020120619172429000_CIT0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.comppsych.2018.11.014","article-title":"Polygenic risk for schizophrenia and associated brain structural changes: a systematic review","volume":"88","author":"van der Merwe","year":"2019","journal-title":"Compr Psychiatry"},{"issue":"3","key":"2020120619172429000_CIT0007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/YCO.0000000000000327","article-title":"Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research","volume":"30","author":"Lavoie","year":"2017","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"2020120619172429000_CIT0008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neures.2013.09.010","article-title":"Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: utility and limitation of the surrogate tissues in research for brain disorders","volume":"77","author":"Horiuchi","year":"2013","journal-title":"Neurosci Res"},{"issue":"8","key":"2020120619172429000_CIT0009","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1007\/s12035-017-0833-7","article-title":"Cannabis users show enhanced expression of CB1-5HT2A receptor heteromers in olfactory neuroepithelium cells","volume":"55","author":"Galindo","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2020120619172429000_CIT0010","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1038\/tp.2014.141","article-title":"Translational potential of olfactory mucosa for the study of neuropsychiatric illness","volume":"5","author":"Borgmann-Winter","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"11","key":"2020120619172429000_CIT0011","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/stem.1220","article-title":"Concise review: patient-derived olfactory stem cells: new models for brain diseases","volume":"30","author":"Mackay-Sim","year":"2012","journal-title":"Stem Cells"},{"key":"2020120619172429000_CIT0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mcn.2016.01.013","article-title":"The microtubular cytoskeleton of olfactory neurons derived from patients with schizophrenia or with bipolar disorder: implications for biomarker characterization, neuronal physiology and pharmacological screening","volume":"73","author":"Ben\u00edtez-King","year":"2016","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"2020120619172429000_CIT0013","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01153516","article-title":"The fine structure of the olfactory mucosa in man","volume":"11","author":"Moran","year":"1982","journal-title":"J Neurocytol"},{"issue":"11\u201312","key":"2020120619172429000_CIT0014","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1242\/dmm.005447","article-title":"Disease-specific, neurosphere-derived cells as models for brain disorders","volume":"3","author":"Matigian","year":"2010","journal-title":"Dis Model Mech"},{"issue":"1","key":"2020120619172429000_CIT0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/mi.3.1.27","article-title":"Recent advances in the neurobiology of schizophrenia","volume":"3","author":"Miyamoto","year":"2003","journal-title":"Mol Interv"},{"issue":"1","key":"2020120619172429000_CIT0016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"8","key":"2020120619172429000_CIT0017","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.euroneuro.2012.10.006","article-title":"Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects","volume":"23","author":"Muguruza","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2\u20133","key":"2020120619172429000_CIT0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2012.07.021","article-title":"Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia","volume":"141","author":"Jenko","year":"2012","journal-title":"Schizophr Res"},{"issue":"2","key":"2020120619172429000_CIT0019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"2020120619172429000_CIT0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0091-3057(00)00477-9","article-title":"Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice","volume":"68","author":"Darmani","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"2020120619172429000_CIT0021","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41386-018-0076-y","article-title":"Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt\/mTOR pathway","volume":"43","author":"Ibarra-Lecue","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"2020120619172429000_CIT0022","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2215-0366(19)30176-2","article-title":"High-potency cannabis and incident psychosis: correcting the causal assumption - Authors\u2019 reply","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"2020120619172429000_CIT0023","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"van der Meer","year":"2015","journal-title":"Psychol Med"},{"issue":"2","key":"2020120619172429000_CIT0024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ps.201400316","article-title":"Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study","volume":"67","author":"Berg\u00e9","year":"2016","journal-title":"Psychiatr Serv"},{"key":"2020120619172429000_CIT0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psychres.2017.01.045","article-title":"Cannabis use, COMT, BDNF and age at first-episode psychosis","volume":"250","author":"Man\u00e9","year":"2017","journal-title":"Psychiatry Res"},{"issue":"32","key":"2020120619172429000_CIT0026","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.2174\/138161212802884753","article-title":"Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox","volume":"18","author":"Ruiz-Veguilla","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"7","key":"2020120619172429000_CIT0027","doi-asserted-by":"crossref","first-page":"e1002194","DOI":"10.1371\/journal.pbio.1002194","article-title":"Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","volume":"13","author":"Vi\u00f1als","year":"2015","journal-title":"PLoS Biol"},{"issue":"1","key":"2020120619172429000_CIT0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr Bull"},{"issue":"1","key":"2020120619172429000_CIT0029","doi-asserted-by":"crossref","first-page":"e013881","DOI":"10.1136\/bmjopen-2016-013881","article-title":"Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode","volume":"7","author":"Keating","year":"2017","journal-title":"BMJ Open"},{"issue":"9831","key":"2020120619172429000_CIT0030","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"2020120619172429000_CIT0031","doi-asserted-by":"crossref","first-page":"P939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"2020120619172429000_CIT0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tics.2011.11.015","article-title":"Cognition in schizophrenia: core psychological and neural mechanisms","volume":"16","author":"Barch","year":"2012","journal-title":"Trends Cogn Sci"},{"key":"2020120619172429000_CIT0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13065su1.02","article-title":"The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness","volume":"75","author":"Keefe","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"2020120619172429000_CIT0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"key":"2020120619172429000_CIT0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.psychres.2016.10.085","article-title":"Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort","volume":"247","author":"Husa","year":"2017","journal-title":"Psychiatry Res"},{"issue":"2","key":"2020120619172429000_CIT0036","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis","volume":"70","author":"D\u00e9sam\u00e9ricq","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2020120619172429000_CIT0037","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nn.4616","article-title":"Antipsychotic-induced Hdac2 transcription via NF-\u03baB leads to synaptic and cognitive side effects","volume":"20","author":"Ibi","year":"2017","journal-title":"Nat Neurosci"},{"issue":"4","key":"2020120619172429000_CIT0038","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jnc.13582","article-title":"Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies","volume":"137","author":"\u0141ukasiewicz","year":"2016","journal-title":"J Neurochem"},{"key":"2020120619172429000_CIT0039","volume-title":"Escala de Inteligencia de Wechsler III","author":"Wechsler","year":"1997"},{"key":"2020120619172429000_CIT0040","volume-title":"Multilingual Aphasia Exam","author":"Benton","year":"1983","edition":"3rd ed"},{"issue":"1","key":"2020120619172429000_CIT0041","first-page":"69","article-title":"Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines","volume":"3","author":"Pastor","year":"2010","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2020120619172429000_CIT0042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2011.07.009","article-title":"A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases","volume":"201","author":"Ben\u00edtez-King","year":"2011","journal-title":"J Neurosci Methods"},{"issue":"3","key":"2020120619172429000_CIT0043","doi-asserted-by":"crossref","first-page":"e12421","DOI":"10.1111\/jpi.12421","article-title":"The role of melatonin in the neurodevelopmental etiology of schizophrenia: a study in human olfactory neuronal precursors","volume":"63","author":"Galvan-Arrieta","year":"2017","journal-title":"J Pineal Res"},{"key":"2020120619172429000_CIT0044","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2017.04.047","article-title":"Human neural stem\/progenitor cells derived from the olfactory epithelium express the TrkB receptor and migrate in response to BDNF","volume":"355","author":"Ortiz-L\u00f3pez","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"2020120619172429000_CIT0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"7664","key":"2020120619172429000_CIT0046","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"issue":"7398","key":"2020120619172429000_CIT0047","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u00b5-opioid receptor bound to a Morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"issue":"3","key":"2020120619172429000_CIT0048","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1007\/s12035-017-0500-z","article-title":"Exfoliated human olfactory neuroepithelium: a source of neural progenitor cells","volume":"55","author":"Jim\u00e9nez-Vaca","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2020120619172429000_CIT0049","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.isci.2019.100794","article-title":"\u0394-Tetrahydrocannabinol increases dopamine D1-D2 receptor heteromer and elicits phenotypic reprogramming in adult primate striatal neurons","volume":"23","author":"Hasbi","year":"2020","journal-title":"iScience"},{"issue":"9","key":"2020120619172429000_CIT0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbagen.2009.06.009","article-title":"Epigenetic mechanisms in schizophrenia","volume":"1790","author":"Roth","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2020120619172429000_CIT0051","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1038\/tp.2013.111","article-title":"Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients","volume":"4","author":"Wockner","year":"2014","journal-title":"Transl Psychiatry"},{"issue":"6","key":"2020120619172429000_CIT0052","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.euroneuro.2019.04.005","article-title":"Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis","volume":"29","author":"Bioque","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"2020120619172429000_CIT0053","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14640748608401616","article-title":"Dementia and working memory","volume":"38","author":"Baddeley","year":"1986","journal-title":"Q J Exp Psychol A"},{"issue":"4","key":"2020120619172429000_CIT0054","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1017\/S1355617704104037","article-title":"Effect of age on forward and backward span tasks","volume":"10","author":"Hester","year":"2004","journal-title":"J Int Neuropsychol Soc"},{"key":"2020120619172429000_CIT0055","doi-asserted-by":"crossref","first-page":"s50","DOI":"10.1192\/bjp.181.43.s50","article-title":"Neurological soft signs in first-episode psychosis: a systematic review","volume":"43","author":"Dazzan","year":"2002","journal-title":"Br J Psychiatry Suppl"},{"issue":"7","key":"2020120619172429000_CIT0056","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2020120619172429000_CIT0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2015.06.008","article-title":"The influence of cannabinoids on learning and memory processes of the dorsal striatum","volume":"125","author":"Goodman","year":"2015","journal-title":"Neurobiol Learn Mem"},{"issue":"3","key":"2020120619172429000_CIT0058","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"2020120619172429000_CIT0059","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41537-017-0032-6","article-title":"Abnormalities of signal transduction networks in chronic schizophrenia","volume":"3","author":"McGuire","year":"2017","journal-title":"npj Schizophr"},{"issue":"3","key":"2020120619172429000_CIT0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/C8MO00173A","article-title":"Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia","volume":"15","author":"Bentea","year":"2019","journal-title":"Mol Omics"},{"issue":"1","key":"2020120619172429000_CIT0061","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biol"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/46\/6\/1547\/34624511\/sbaa038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/46\/6\/1547\/34624511\/sbaa038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T02:24:49Z","timestamp":1607307889000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/46\/6\/1547\/5816357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,4,6]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaa038","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2020,4,6]]}}}